Does altered LH pulsatility and a high LH:FSH ratio in PCOS impair ovulation and cause luteal phase progesterone deficiency?

Polycystic Ovary Syndrome (PCOS) is characterized by a fundamental disruption of the hypothalamic-pituitary-ovarian (HPO) axis. In this condition, the GnRH pulse generator in the brain operates at an abnormally high frequency, which dictates the downstream hormonal imbalances that impair fertility and cycle regularity.

Clinical and effectiveness evidence

Research consistently demonstrates that an elevated LH:FSH ratio is a primary marker for ovulatory dysfunction in PCOS. Clinical data indicates that an LH:FSH ratio of ≥1 is associated with a 58% reduction in the odds of ovulation (OR=0.42) compared to ratios below 1. When the ratio reaches ≥3, the likelihood of successful ovulation decreases further. Studies in PCOS cohorts show that even when ovulation does occur, the luteal phase—the period following ovulation—is often shorter or characterized by lower progesterone levels. Specifically, peak progesterone levels in the mid-luteal phase are frequently lower in individuals with PCOS than in healthy controls, confirming a high prevalence of luteal phase deficiency (LPD).

Mechanistic explanations

The link between hormonal pulsatility and reproductive failure involves several convergent pathways:

• Neuroendocrine signaling: The rapid GnRH pulse frequency upregulates the LH $\beta$-subunit while downregulating the FSH $\beta$-subunit. This creates a state of "tonic" high LH and relative FSH deficiency.
• Follicular arrest: Insufficient FSH prevents the selection and maturation of a dominant follicle. Simultaneously, high LH overstimulates theca cells to produce excess androgens, which arrests follicle development at the antral stage.
• Impaired luteinization: The quality of the corpus luteum is determined by the health of the preceding follicle. High LH levels cause premature luteinization of granulosa cells in immature follicles.
• Steroidogenic dysfunction: Elevated LH levels ironically disrupt progesterone biosynthesis in the corpus luteum by reducing the expression of the steroidogenic acute regulatory protein (StAR). Without adequate StAR, the luteal cells cannot efficiently convert cholesterol into progesterone, leading to the clinical presentation of LPD.

Bottom line

The evidence strongly supports the claim that altered LH pulsatility and high LH:FSH ratios in PCOS impair ovulation and lead to luteal phase deficiency. This occurs because the hormonal imbalance disrupts both the initial maturation of the egg and the subsequent ability of the corpus luteum to produce sufficient progesterone.